Deciphering complex mechanisms of resistance and loss of potency through coupled molecular dynamics and machine learning [preprint]
Leidner, Florian ; Yilmaz, Nese Kurt ; Schiffer, Celia A.
Citations
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Document Type
Publication Date
Subject Area
Embargo Expiration Date
Link to Full Text
Abstract
Drug resistance threatens many critical therapeutics through mutations in the drug target. The molecular mechanisms by which combinations of mutations, especially involving those distal from the active site, alter drug binding to confer resistance are poorly understood and thus difficult to counteract. A strategy coupling parallel molecular dynamics simulations and machine learning to identify conserved mechanisms underlying resistance was developed. A series of 28 HIV-1 protease variants with up to 24 varied substitutions were used as a rigorous model of this strategy. Many of the mutations were distal from the active site and the potency to darunavir varied from low pM to near μM. With features extracted from molecular dynamics simulations, elastic network machine learning was applied to correlate physical interactions at the molecular level with potency loss. This fit to within 1 kcal/mol of experimental potency for both the training and test sets, outperforming MM/GBSA calculations. Feature reduction resulted in a model with 4 specific features that correspond to interactions critical for potency regardless of enzyme variant. These predictive features throughout the enzyme would not have been identified without dynamics and machine learning and specifically varied with potency. This approach enables capturing the conserved dynamic molecular mechanisms by which complex combinations of mutations confer resistance and identifying critical interactions which serve as bellwethers over a wide range of inhibitor potency. Machine learning models leveraging molecular dynamics can thus elucidate mechanisms that confer loss of affinity due to variations distal from the active site, such as in drug resistance.
Source
bioRxiv 2020.06.08.139105; doi: https://doi.org/10.1101/2020.06.08.139105. Link to preprint on bioRxiv service.
Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
Permanent Link to this Item
PubMed ID
Other Identifiers
Notes
Funding and Acknowledgements
Corresponding Author
Related Resources
Now published in J Chem Theory Comput., doi: 10.1021/acs.jctc.0c01244